Jérôme Lemoine

Dr. Jérôme Lemoine


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2000 in Journal of Biological Chemistry
Verified
Journal Article
Open access
TFThierry Fontaine
Thierry Fontaine
CSCatherine Simenel
Catherine Simenel
GDGuy Dubreucq
Guy Dubreucq
OAOlivier Adam
Olivier Adam
MDMuriel Delepierre
Muriel Delepierre
JLJean-Paul Latgé
Jean-Paul Latgé
Physical and biological properties of the fungal cell wall are determined by the composition and arrangement of the structural polysaccharides. Cell wall polymers of fungi are classically divided into two groups depending on their solubility in hot alkali. We have analyzed the alkali-insoluble fraction of the Aspergillus fumigatus cell wall, which is the fraction believed to be responsible for fungal cell wall rigidity. Using enzymatic digestions with recombinant endo-beta-1,3-glucanase and chitinase, fractionation by gel filtration, affinity chromatography with immobilized lectins, and high performance liquid chromatography, several fractions that contained specific interpolysaccharide covalent linkages were isolated. Unique features of the A. fumigatus cell wall are (i) the absence of beta-1,6-glucan and (ii) the presence of a linear beta-1, 3/1,4-glucan, never previously described in fungi. Galactomannan, chitin, and beta-1,3-glucan were also found in the alkali-insoluble fraction. The beta-1,3-glucan is a branched polymer with 4% of beta-1,6 branch points. Chitin, galactomannan, and the linear beta-1, 3/1,4-glucan were covalently linked to the nonreducing end of beta-1, 3-glucan side chains. As in Saccharomyces cerevisiae, chitin was linked via a beta-1,4 linkage to beta-1,3-glucan. The data obtained suggested that the branching of beta-1,3-glucan is an early event in the construction of the cell wall, resulting in an increase of potential acceptor sites for chitin, galactomannan, and the linear beta-1,3/1,4-glucan.

1 May 2009 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
TFTanguy Fortin
Tanguy Fortin
ASArnaud Salvador
Arnaud Salvador
JCJean Philippe Charrier
Jean Philippe Charrier
CLCristof Lenz
Cristof Lenz
XLXavier Lacoux
Xavier Lacoux
JLJérôme Lemoine
Jérôme Lemoine
Proteomics discovery leads to a list of potential protein biomarkers that have to be subsequently verified and validated with a statistically viable number of patients. Although the most sensitive, the development of an ELISA test is time-consuming when antibodies are not available and need to be conceived. Mass spectrometry analysis driven in quantitative multiple reaction monitoring mode is now appearing as a promising alternative to quantify proteins in biological fluids. However, all the studies published to date describe limits of quantitation in the low μg/ml range when no immunoenrichment of the target protein is applied, whereas the concentration of known clinical biomarkers is usually in the ng/ml range. Using prostate-specific antigen as a model biomarker, we now provide proof of principle that mass spectrometry enables protein quantitation in a concentration range of clinical interest without immunoenrichment. We have developed and optimized a robust sample processing method combining albumin depletion, trypsin digestion, and solid phase extraction of the proteotypic peptides starting from only 100 μl of serum. For analysis, mass spectrometry was coupled to a conventional liquid chromatography system using a 2-mm-internal diameter reverse phase column. This mass spectrometry-based strategy was applied to the quantitation of prostate-specific antigen in sera of patients with either benign prostate hyperplasia or prostate cancer. The quantitation was performed against an external calibration curve by interpolation, and results showed good correlation with existing ELISA tests applied to the same samples. This strategy might now be implemented in any clinical laboratory or certified company for further evaluation of any putative biomarker in the low ng/ml range of serum or plasma.

19 October 2009 in Analytical Chemistry
Verified
Journal Article
Closed access
TFT. Fortin
T. Fortin
ASA. Salvador
A. Salvador
JCJ. P. Charrier
J. P. Charrier
CLC. Lenz
C. Lenz
FBF. Bettsworth
F. Bettsworth
JLJérôme Lemoine
Jérôme Lemoine

1 March 1993 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Closed access
JLJérôme Lemoine
Jérôme Lemoine
BFBernard Fournet
Bernard Fournet
DDDominique Despeyroux
Dominique Despeyroux
KJKeith R. Jennings
Keith R. Jennings
RRRaoul Rosenberg
Raoul Rosenberg
EHEdmond de Hoffmann
Edmond de Hoffmann

1 June 2004 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
CCCaroline Cieniewski-Bernard
Caroline Cieniewski-Bernard
BBBruno Bastide
Bruno Bastide
TLTony Lefebvre
Tony Lefebvre
JLJérôme Lemoine
Jérôme Lemoine
YMYvonne Mounier
Yvonne Mounier
JMJean-Claude Michalski
Jean-Claude Michalski
O-linked N-acetylglucosaminylation (O-GlcNAc) is a regulatory post-translational modification of nucleo-cytoplasmic proteins that has a complex interplay with phosphorylation. O-GlcNAc has been described as a nutritional sensor, the level of UDP-GlcNAc that serves as a donor for the uridine diphospho-N-acetylglucosamine:polypeptide β-N-acetyl-glucosaminyltransferase being regulated by the cellular fate of glucose. Because muscular contraction is both dependent on glucose metabolism and is highly regulated by phosphorylation/dephosphorylation processes, we decided to investigate the identification of O-GlcNAc-modified proteins in skeletal muscle using a proteomic approach. Fourteen proteins were identified as being O-GlcNAc modified. These proteins can be classified in three main classes: i) proteins implicated in the signal transduction and in the translocation between the cytoplasm and the nucleus or structural proteins, ii) proteins of the glycolytic pathway and energetic metabolism, and iii) contractile proteins (myosin heavy chain). A decrease in the O-GlcNAc level was measured in the slow postural soleus muscle after 14-day hindlimb unloading, a model of functional atrophy characterized by a decrease in the force of contraction. These results strongly suggest that O-GlcNAc modification may serve as an important regulation system in skeletal muscle physiology.

1 July 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
Aurélie TasiemskiAurélie Tasiemski
Aurélie Tasiemski
FVFranck Vandenbulcke
Franck Vandenbulcke
GMGuillaume Mitta
Guillaume Mitta
JLJérôme Lemoine
Jérôme Lemoine
CLChristophe Lefebvre
Christophe Lefebvre
MSMichel Salzet
Michel Salzet
Two novel antimicrobial peptides named theromacin and theromyzin were isolated and characterized from the coelomic liquid of the leech Theromyzon tessulatum. Theromacin is a 75-amino acid cationic peptide containing 10 cysteine residues arranged in a disulfide array showing no similarities with other known antimicrobial peptides. Theromyzin is an 86-amino acid linear peptide and constitutes the first anionic antimicrobial peptide observed in invertebrates. Both peptides exhibit activity directed against Gram-positive bacteria. Theromacin and theromyzin cDNAs code precursor molecules containing a putative signal sequence directly followed by the mature peptide. The enhancement of theromacin and theromyzin mRNA levels has been observed after blood meal ingestion and upon bacterial challenge. In situ hybridization revealed that both genes are expressed in large fat cells in contact with coelomic cavities. Gene products were immunodetected in large fat cells, in intestinal epithelia, and at the epidermis level. In addition, a rapid release of the peptides into the coelomic liquid was observed after bacterial challenge. The presence of antimicrobial peptide genes in leeches and their expression in a specific tissue functionally resembling the insect fat body provide evidence for the first time of an antibacterial response in a lophotrochozoan comparable to that of holometabola insects.